Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05854433Enrolling By Invitation
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
Myotonic Dystrophy Type 1Myotonic Dystrophy Type 2
PrincipalinvestigatorStart date: 2023-04-26

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Wake Forest University Health Sciences

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Johann Hamel, MD

University of Rochester Medical Center, Department of Neurology

Moderately Similar
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1Myotonic Dystrophy Type 2

Worked with same sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)
Similarity Score30%

Virginia Arechavala-Gomeza, Ph.D.

IIS Biobizkaia

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Gisela Nogales Gadea, Ph.D.

Germans Trias i Pujol Research Institute

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Baziel van Engelen, Prof

Radboud University Nijmegen Medical Centre, The Netherlands

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Grainne Gorman, Dr

Newcastle University

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Benedikt Schoser, MD

Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany

Related
2 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 2
Similarity Score15%

Stephan Wenninger, PD Dr. med.

Neurologist

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 2
Similarity Score15%

Richard Moxley, M.D.

University of Rochester Neuromuscular Disease Center

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Hanife Hale Hekim, MD

Antalya Training and Research Hospital

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Benedikt Schoser, Prof

Munich University, Germany

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy Type 1
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05854433PrincipalInvestigator

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

Myotonic Dystrophy Type 1Myotonic Dystrophy Type 2
Enrolling By Invitation

All 1 trials loaded